SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?


To: Joseph B. Schmidt who wrote (8406)6/9/2005 9:51:45 AM
From: Galirayo  Respond to of 23958
 
Siemens and SEQUENOM Expand Molecular Diagnostics Working Group to Include European Collaborator Bioscientia
Thursday June 9, 6:00 am ET

SAN DIEGO, June 9 /PRNewswire-FirstCall/ -- Bioscientia, a leading international reference laboratory will participate as a European site for a joint working group on molecular diagnostics initiated by SEQUENOM, Inc. (Nasdaq: SQNM - News) and Siemens Medical Solutions of Siemens AG (NYSE: SI - News). SEQUENOM's MassARRAY® Compact System, a genetics analysis platform, will be installed at Bioscientia's clinical reference laboratory facility in Germany to benchmark the MassARRAY System in a molecular diagnostic testing environment.

[snip]
biz.yahoo.com